Spontane retroperitoneale und Rektusscheidenhämatome und ihre interventionelle Therapie: ein Review

Zussamenfassung

Hintergrund Retroperitoneale und Rektusscheidenhämatome (RH/RSH) stellen ein Krankheitsbild dar, das unter anderem wegen unspezifischer klinischer Symptomatik und des drohenden Risikos einer Exsanguination bzw. Folgen des Blutverlustes, Mortalitätsraten bis zu 30 % aufweist. Ätiologisch werden traumatische, iatrogene und spontane Subtypen unterschieden. Mit in der Literatur beschriebenen Risikofaktoren eines Lebensalters > 65 Jahre und der Einnahme antikoagulativer Medikation werden steigende Inzidenzen insbesondere des spontanen Subtyps der RH/SRH in der alternden Gesellschaft prognostiziert.

Material und Methodik Analyse, Resümee und Diskussion publizierter Grundlagenarbeiten und Expertenempfehlungen.

Ergebnisse Am häufigsten wird das Vorliegen abdomineller Schmerzen im Rahmen der klinischen Untersuchung beschrieben; in Abhängigkeit vom Ausmaß des Volumenverlustes können die Symptome eines abdominellen Kompartments und eines hämorrhagischen Schocks auftreten. Die Computertomographie-Angiographie (CTA), mit hoher Sensitivität und Spezifizität für das Vorliegen aktiver Blutungen, spielt die entscheidende Rolle in der Detektion von RH und RSH. Das Therapiemanagement basiert auf verschiedenen Säulen, welche neben konservativen Maßnahmen (Volumenersatz, Optimierung der Gerinnungsparameter), chirurgische und interventionelle Maßnahmen umfassen, die eng aufeinander abgestimmt werden. Aufgrund ihrer geringeren Invasivität bei simultan hohen technischen und klinischen Erfolgsraten hat insbesondere die Säule der interventionellen Therapie zunehmend an Bedeutung gewonnen.

Schlussfolgerung Das Therapiemanagement von Patienten/innen mit RH/SRH erfordert eine niedrige klinische Verdachtsschwelle und die Zusammenarbeit in einem interdisziplinären Team zur bestmöglichen Therapiefindung. Die transarterielle Embolisation erfordert eine systematische, standardisierte Abfolge der Blutungsdetektion und bietet Vorteile hinsichtlich technischer und klinischer Erfolgsraten.

Kernaussagen: 

• Retroperitoneale und Rektusscheidenhämatome können sich klinisch sehr heterogen und unspezifisch präsentieren. Rasche Diagnosen sind aufgrund einer relativ hohen Mortalität (ca. 12–30 %) essenziell.

• Haupt-Risikofaktoren sind ein Alter > 65 Jahre und die Einnahme von Antikoagulantien, deren Verordnung in den vergangenen 10 Jahren um das 2,5-fache gestiegen ist. Seltener sind Koagulopathien, retroperitoneale Raumforderungen und Hämodialyse als ursächlich beschrieben

• Die Computertomographie-Angiographie (CTA) besitzt eine hohe Sensitivität und Spezifizität für das Vorliegen aktiver Blutungen und hat die Diagnostische Subtraktionsangiographie (DSA) ersetzt.

• Die Therapie sollte in einem multidisziplinären Setting, unter Einbezug der Inneren Medizin, der Radiologie und der Chirurgie erfolgen. Hauptindikationen für die Durchführung einer Embolisation sind der Nachweis eines aktiven Kontrastmittelaustritts in der CTA und das Vorliegen abdomineller Schmerzen. In Fällen ohne Nachweis einer aktiven Blutung und stabiler Vitalparameter können konservative Therapiemaßnahmen ausreichen. Die chirurgische Therapie bleibt oftmals therapierefraktären Blutungen mit Symptomen eines abdominellen Kompartments vorbehalten.

• Eine systematische, standardisierte Abfolge der Blutungsdetektion in der DSA scheint Vorteile hinsichtlich technischer und klinischer Erfolgsraten zu bieten.

Abstract

Background Retroperitoneal and rectus sheath hemorrhage (RRSH) has been described as a potentially fatal condition with mortality rates of up to 30 % due to the risk of exsanguination in combination with often nonspecific clinical symptoms. Patients at risk are > 65 years of age as well as those receiving anticoagulation/antiplatelet medicine. Classifications based on etiology consist of trauma, surgery, and/or underlying vascular pathologies, though spontaneous occurrences without precipitating factors have been reported and are expected to increase with the high number of patients undergoing anticoagulant therapy.

Method Analysis, summary, and discussion of published review articles and expert recommendations.

Results The most commonly described symptom during clinical examination is abdominal pain. However, depending on the volume loss, clinical symptoms may include signs of abdominal compartment and hemorrhagic shock. Computed tomography angiography (CTA) with high sensitivity and specificity for the presence of active bleeding plays an important role in the detection of RH and RSH. Therapy management is based on different pillars, which include surgical and interventional measures in addition to conservative measures (volume replacement, optimization of coagulation parameters). Due to its lower invasiveness with simultaneously high technical and clinical success rates, interventional therapy in particular has gained increasing importance.

Conclusion Diagnostic and therapeutic workup of the patients by an interdisciplinary team is essential for optimal patient care. In case of transcatheter arterial embolization, a standardized approach to the detection of bleeding sites within the vascular territory of the core hematoma appears to favorably influence success and patient outcome.

Key points: 

• The clinical presentation of retroperitoneal and rectus sheath hematomas can be very heterogeneous and nonspecific. Quick diagnosis is essential due to the relatively high mortality rate (approx. 12–30 %).

• The main risk factors are age > 65 years and the intake of anticoagulants, the use of which has increased 2.5 times in the last 10 years. Coagulopathies, retroperitoneal masses, and hemodialysis are less common causes.

• Computed tomography angiography (CTA) has a high sensitivity and specificity for the presence of active bleeding and has replaced diagnostic subtraction angiography (DSA).

• Treatment should be performed in a multidisciplinary setting with the inclusion of internal medicine, radiology, and surgery. The main indications for embolization are the detection of active contrast extravasation on CTA and the presence of abdominal pain. In cases without active bleeding and with stable vital parameters, conservative treatment measures can be sufficient. Surgical treatment is often reserved for treatment-refractory bleeding with symptoms of abdominal compartment.

• A systematic standardized approach to the detection of bleeding on DSA seems to have advantages regarding technical and clinical success rates.

Citation Format

• Becker LS, Dewald CLA et al. Spontaneous retroperitoneal and rectus sheath hematomas and their interventional therapy: a review. Fortschr Röntgenstr 2024; 196: 163 – 175

Key words

abdominal wall - retroperitoneum - angiography - embolization

Publikationsverlauf

Eingereicht: 13. April 2023

Angenommen: 01. Juli 2023

Artikel online veröffentlicht:
15. August 2023

• Literatur

• 1 Ritter U. Extensive retroperitoneal hematoma following diagnostic anesthesia of the lumbar sympathetic nerve. Chirurg 1950; 21: 434-435
• 2 Chan YC, Morales JP, Reidy JF. et al. Management of spontaneous and iatrogenic retroperitoneal haemorrhage: conservative management, endovascular intervention or open surgery?. Int J Clin Pract 2008; 62: 1604-1613 DOI: 10.1111/j.1742-1241.2007.01494.x.
• 3 Tani R, Sofue K, Sugimoto K. et al. The utility of transarterial embolization and computed tomography for life-threatening spontaneous retroperitoneal hemorrhage. Jpn J Radiol 2019; 37: 328-335 DOI: 10.1007/s11604-019-00815-5.
• 4 Rosen Michael HI. (28.07.2022) Spontaneous retroperitoneal hematoma and rectus sheath hematoma. UpToDate. Accessed 14.02.2023 2023
• 5 Schulze FP, Markus PM, Stöhr G. et al. Management von retroperitonealen Hämatomen bei Patienten unter antikoagulativer Therapie (Management of retroperitoneal hematoma in patients on anticoagulative therapy). Viszeralchirurgie 2001; 36: 91-97 DOI: 10.1055/s-2001-12719.
• 6 Geeraerts T, Chhor V, Cheisson G. et al. Clinical review: initial management of blunt pelvic trauma patients with haemodynamic instability. Crit Care 2007; 11: 204 DOI: 10.1186/cc5157.
• 7 Mondie C, Maguire NJ, Rentea RM. Retroperitoneal Hematoma. In: StatPearls. Treasure Island (FL): 2022
• 8 Daly KP, Ho CP, Persson DL. et al. Traumatic Retroperitoneal Injuries: Review of Multidetector CT Findings. Radiographics 2008; 28: 1571-1590 DOI: 10.1148/rg.286075141.
• 9 Titone C, Lipsius M, Krakauer JS. “Spontaneous” hematoma of the rectus abdominis muscle: critical review of 50 cases with emphasis on early diagnosis and treatment. Surgery 1972; 72: 568-572
• 10 Klausenitz C, Kuehn JP, Noeckler K. et al. Efficacy of transarterial embolisation in patients with life-threatening spontaneous retroperitoneal haematoma. Clin Radiol 2021; 76: 157.e111-157.e118 DOI: 10.1016/j.crad.2020.10.003.
• 11 Maluenda G, Mitulescu L, Ben-Dor I. et al. Retroperitoneal hemorrhage after percutaneous coronary intervention in the current practice era: clinical outcomes and prognostic value of abdominal/pelvic computed tomography. Catheter Cardiovasc Interv 2012; 80: 29-36 DOI: 10.1002/ccd.23200.
• 12 Pode D, Caine M. Spontaneous retroperitoneal hemorrhage. J Urol 1992; 147: 311-318 DOI: 10.1016/s0022-5347(17)37224-5.
• 13 Seldinger SI. Catheter replacement of the needle in percutaneous arteriography; a new technique. Acta radiol 1953; 39: 368-376 DOI: 10.3109/00016925309136722.
• 14 Berna JD, Garcia-Medina V, Guirao J. et al. Rectus sheath hematoma: diagnostic classification by CT. Abdom Imaging 1996; 21: 62-64 DOI: 10.1007/s002619900011.
• 15 Hatjipetrou A, Anyfantakis D, Kastanakis M. Rectus sheath hematoma: a review of the literature. Int J Surg 2015; 13: 267-271 DOI: 10.1016/j.ijsu.2014.12.015.
• 16 Dohan A, Darnige L, Sapoval M. et al. Spontaneous soft tissue hematomas. Diagn Interv Imaging 2015; 96: 789-796 DOI: 10.1016/j.diii.2015.03.014.
• 17 Kasotakis G. Retroperitoneal and rectus sheath hematomas. Surg Clin North Am 2014; 94: 71-76 DOI: 10.1016/j.suc.2013.10.007.
• 18 Wang F, Wang F. The diagnosis and treatment of traumatic retroperitoneal hematoma. Pak J Med Sci 2013; 29: 573-576 DOI: 10.12669/pjms.292.3168.
• 19 Baekgaard JS, Eskesen TG, Lee JM. et al. Spontaneous Retroperitoneal and Rectus Sheath Hemorrhage-Management, Risk Factors and Outcomes. World J Surg 2019; 43: 1890-1897 DOI: 10.1007/s00268-019-04988-y.
• 20 McCort JJ. Intraperitoneal and retroperitoneal hemorrhage. Radiol Clin North Am 1976; 14: 391-405
• 21 Ivascu FA, Janczyk RJ, Bair HA. et al. Spontaneous retroperitoneal hemorrhage. Am J Surg 2005; 189: 345-347 DOI: 10.1016/j.amjsurg.2004.11.020.
• 22 Shah RD, Nagar S, Shanley CJ. et al. Factors affecting the severity of spontaneous retroperitoneal hemorrhage in anticoagulated patients. Am J Surg 2008; 195: 410-412 DOI: 10.1016/j.amjsurg.2007.12.003.
• 23 Sunga KL, Bellolio MF, Gilmore RM. et al. Spontaneous retroperitoneal hematoma: etiology, characteristics, management, and outcome. J Emerg Med 2012; 43: e157-e161 DOI: 10.1016/j.jemermed.2011.06.006.
• 24 Maratka HSZVJ. Syndrom krvμcení do m. psoas prispevek ke kromplkacim protisrazlive lecvy. Vnitrni Lekar; 1961: 1131
• 25 Kwok CS, Kontopantelis E, Kinnaird T. British Cardiovascular Intervention S, National Institute of Cardiovascular Outcomes R. et al. Retroperitoneal Hemorrhage After Percutaneous Coronary Intervention: Incidence, Determinants, and Outcomes as Recorded by the British Cardiovascular Intervention Society. Circ Cardiovasc Interv 2018; 11: e005866 DOI: 10.1161/CIRCINTERVENTIONS.117.005866.
• 26 Colakoglu MK, Ozdemir A, Kalcan S. et al. Spontaneous abdomen and abdominal wall hematomas due to anticoagulant/antiplatelet use: Surgeons’ perspective in a single center. Ulus Travma Acil Cerrahi Derg 2020; 26: 50-54 DOI: 10.14744/tjtes.2019.32485.
• 27 Sahu KK, Mishra AK, Lal A. et al. Clinical spectrum, risk factors, management and outcome of patients with retroperitoneal hematoma: a retrospective analysis of 3-year experience. Expert Rev Hematol 2020; 13: 545-555 DOI: 10.1080/17474086.2020.1733963.
• 28 Warren MH, Bhattacharya B, Maung AA. et al. Contemporary management of spontaneous retroperitoneal and rectus sheath hematomas. Am J Surg 2020; 219: 707-710 DOI: 10.1016/j.amjsurg.2019.05.002.
• 29 Kalinowski EA, Trerotola SO. Postcatheterization retroperitoneal hematoma due to spontaneous lumbar arterial hemorrhage. Cardiovasc Intervent Radiol 1998; 21: 337-339 DOI: 10.1007/s002709900272.
• 30 Wong JM, Maddox TM, Kennedy K. et al. Comparing Major Bleeding Risk in Outpatients With Atrial Fibrillation or Flutter by Oral Anticoagulant Type (from the National Cardiovascular Disease Registry’s Practice Innovation and Clinical Excellence Registry). Am J Cardiol 2020; 125: 1500-1507 DOI: 10.1016/j.amjcard.2020.02.028.
• 31 Gonzalez C, Penado S, Llata L. et al. The clinical spectrum of retroperitoneal hematoma in anticoagulated patients. Medicine (Baltimore) 2003; 82: 257-262 DOI: 10.1097/01.md.0000085059.63483.36.
• 32 De Blasis I, Vinci V, Sergi ME. et al. Early and late onset complications of gynaecologic surgery: a multimodality imaging approach. Facts Views Vis Obgyn 2017; 9: 5-14
• 33 Salemis NS, Gourgiotis S, Karalis G. Diagnostic evaluation and management of patients with rectus sheath hematoma. A retrospective study. Int J Surg 2010; 8: 290-293 DOI: 10.1016/j.ijsu.2010.02.011.
• 34 Feliciano DV. Management of traumatic retroperitoneal hematoma. Ann Surg 1990; 211: 109-123 DOI: 10.1097/00000658-199002000-00001.
• 35 Wortman JR, Landman W, Fulwadhva UP. et al. CT angiography for acute gastrointestinal bleeding: what the radiologist needs to know. Br J Radiol 2017; 90: 20170076 DOI: 10.1259/bjr.20170076.
• 36 Nusbaum M, Baum S, Blakemore WS. et al. Demonstration of Intra-Abdominal Bleeding by Selective Arteriography. Visualization of Celiac and Superior Mesenteric Arteries. JAMA 1965; 191: 389-390 DOI: 10.1001/jama.1965.03080050035009.
• 37 Becker LS, Stöhr F, Maus V. et al. Intraarterial embolizations in life-threatening spontaneous retroperitoneal and rectus sheath hemorrhage (SRRSH): a three-center experience. Emerg Radiol 2023; DOI: 10.1007/s10140-023-02137-6.
• 38 Bosel J, Steiner T. Reversal of oral anticoagulation in intracranial hemorrhage. Dtsch Med Wochenschr 2010; 135: 2366-2369 DOI: 10.1055/s-0030-1269401.
• 39 Tiralongo F, Seminatore S, Di Pietro S. et al. Spontaneous Retroperitoneal Hematoma Treated with Percutaneous Transarterial Embolization in COVID-19 Era: Diagnostic Findings and Procedural Outcome. Tomography 2022; 8: 1228-1240 DOI: 10.3390/tomography8030101.
• 40 Torres GM, Cernigliaro JG, Abbitt PL. et al. Iliopsoas compartment: normal anatomy and pathologic processes. Radiographics 1995; 15: 1285-1297 DOI: 10.1148/radiographics.15.6.8577956.
• 41 Nadjiri J, Schachtner B, Bucker A. et al. Nationwide Provision of Radiologically-guided Interventional Measures for the Supportive Treatment of Tumor Diseases in Germany – An Analysis of the DeGIR Registry Data. Fortschr Röntgenstr 2022; 194: 993-1002 DOI: 10.1055/a-1735-3615.
• 42 Isokangas JM, Perala JM. Endovascular embolization of spontaneous retroperitoneal hemorrhage secondary to anticoagulant treatment. Cardiovasc Intervent Radiol 2004; 27: 607-611 DOI: 10.1007/s00270-004-0219-x.
• 43 Panetta T, Sclafani SJ, Goldstein AS. et al. Percutaneous transcatheter embolization for massive bleeding from pelvic fractures. J Trauma 1985; 25: 1021-1029
• 44 Popov M, Sotiriadis C, Gay F. et al. Spontaneous Intramuscular Hematomas of the Abdomen and Pelvis: A New Multilevel Algorithm to Direct Transarterial Embolization and Patient Management. Cardiovasc Intervent Radiol 2017; 40: 537-545 DOI: 10.1007/s00270-017-1590-8.
• 45 Sharafuddin MJ, Andresen KJ, Sun S. et al. Spontaneous extraperitoneal hemorrhage with hemodynamic collapse in patients undergoing anticoagulation: management with selective arterial embolization. J Vasc Interv Radiol 2001; 12: 1231-1234 DOI: 10.1016/s1051-0443(07)61686-8.
• 46 Wacker F, Wolf KJ, Fobbe F. Percutaneous vascular access guided by color duplex sonography. Eur Radiol 1997; 7: 1501-1504 DOI: 10.1007/s003300050324.
• 47 Günther RWT, Manfred; Albrecht, Thomas; Apitzsch, Jonas Christoph; Aschenbach, René; Balzer, Jörn O.; Berlis, Ansgar; Berthold, Lars Daniel; Bruners, Philipp; Buchbender, Christian;, Burbelko MC, Stephan; Das, Marco; de Graaf, Rick; Düx, Markus; Eivazi, Behfar; Fischbach, Roman; Frese, Jan Paul; Friebe, Björn; Görg, Christian; Greiner, Andreas; Gross-Fengels, Walter; Haage, Patrick; Hass, Peter; Hauenstein, Karlheinz; Henzler, Dietrich; Hoffmann, Ralf-Thorsten; Hoffmann, Rüdiger; Hohl, Christian; Hundt, Walter; Huppert, Peter; Ittrich, Harald; Kamper, Lars; Katoh, Marcus;, Ketelsen DK, Joachim; Keulers, Annika; Kickuth, Ralph; Kröncke, Thomas; Kröpil, Patric;, Krombach GAK, Daniel; Lanzman, Rotem S.; Liersch, Peter; Mathys, Christian; Mensel, Birger; Minko, Peter; Mohnike, Konrad; Moritz, Jörg Detlev; Müller-Hülsbeck, Stefan; Müller-Wille, René;, Nähle CPP, Philipp M.; Penzkofer, Tobias; Pieper, Claus Christian; Ragg, Johann Christof;, Schild HHS, Christoph; Schrading, Simone; Seyfer, Perla; Streitparth, Florian; Strunk, Holger; Syha, Roland; Teichgräber, Ulf K. M.; Thomas, Martin; Thurnher, Siegfried; Trenker, Corinna;, Trumm CGV, Dierk; Wagner, Joachim; Wohlgemuth, Walter A.; Wolf, Florian; Zorger, Niels. Interventionelle Radiologie. Mahnken, Andreas H.; Thomas, Christoph; Wilhelm, Kai 2019 DOI: 10.1055/b-005-143315
• 48 Leonardi M, Barbara C, Simonetti L. et al. Glubran 2: a new acrylic glue for neuroradiological endovascular use. Experimental study on animals. Interventional neuroradiology: journal of peritherapeutic neuroradiology, surgical procedures and related neurosciences 2002; 8 (03) 245-250 DOI: 10.1177/159101990200800304.
• 49 Vollherbst DF, Chapot R, Bendszus M. et al. Glue, Onyx, Squid or PHIL? Liquid Embolic Agents for the Embolization of Cerebral Arteriovenous Malformations and Dural Arteriovenous Fistulas. Clin Neuroradiol 2022; 32: 25-38 DOI: 10.1007/s00062-021-01066-6.
• 50 Llitjos JF, Daviaud F, Grimaldi D. et al. Ilio-psoas hematoma in the intensive care unit: a multicentric study. Ann Intensive Care 2016; 6: 8 DOI: 10.1186/s13613-016-0106-z.
• 51 Kunkala MR, Kehl J, Zielinski MD. Spontaneous rectus sheath hematomas: when to restart anticoagulation?. World J Surg 2013; 37: 2555-2559 DOI: 10.1007/s00268-013-2158-7.
• 52 Sanchez-Gonzalez A, Riancho-Zarrabeitia L, Salmon-Gonzalez Z. et al. Clinical spectrum of patients with spontaneous retroperitoneal hematomas. Med Clin (Barc) 2015; 145: 301-304 DOI: 10.1016/j.medcli.2015.04.033.
• 53 Granger C, Guedeney P, Collet JP. Antithrombotic Therapy Following Transcatheter Aortic Valve Replacement. J Clin Med 2022; 11 DOI: 10.3390/jcm11082190.
• 54 Genereux P, Cohen DJ, Mack M. et al. Incidence, predictors, and prognostic impact of late bleeding complications after transcatheter aortic valve replacement. J Am Coll Cardiol 2014; 64: 2605-2615 DOI: 10.1016/j.jacc.2014.08.052.